Download Initiating Clinical Research - Leicestershire Partnership NHS Trust

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Pharmacogenomics wikipedia , lookup

Transcript
Type
NHS provider
Performance in Initiating
Leicestershire Partnership NHS Trust
Id
Research Ethics
Committee
Reference
Number
Name of Trial
Date of
Receipt of
VRA
Date of
NHS
Permission
First
Patient
Recruited?
Date of
First
Patient
Recruite
d
Duration
between
VRA and
NHS
Permissi
on
70879
14/LO/0055
Improving
outcomes in adults
with epilepsy and
intellectual
disability: A cluster
randomised
controlled trial of
nurse-led epilepsy
management
(EpAID)
15/06/2015
29/06/201
5
Yes
22/07/20
15
70880
14/NW/0297
11/02/2015
20/02/201
5
Yes
70881
14/NI/0069
21/12/2014
05/01/201
5
70882
14/SC/1340
17/09/2015
70883
09/H1005/28
EQUIP: Enhancing
the quality of user
involved care
planning in mental
health services
(EQUIP): Clinical
randomised control
trial and process
evaluation
A randomised
controlled trial of
calcium channel
blockade with
amlodipine for the
treatment of
subcortical
ischaemic vascular
dementia
LEGATO-HD
(Laquinimod
Efficacy and Safety
in a GlobAl Trial Of
HD)
Molecular Genetics
of Adverse Drug
Reactions
10/09/2015
Showing records 1 to 5 of 5.
Pages: 1
Duration
between
VRA and
First
Patient
Benchmark
Met
14
Duration
between
NHS
Permissi
on and
First
Patient
23
A - Permissions
delayed/denied
BSuspended
by sponsor
CClosed
by
sponsor
DSponsor
Delays
E - Staff
availability
issues
F - No
patients
seen
37
Yes
10/03/20
15
9
18
27
Yes
Yes
12/06/20
15
15
158
173
No
Y
28/09/201
5
Yes
20/12/20
15
11
83
94
No
Y
01/10/201
5
Yes
24/11/20
15
21
54
75
No
Y
Y
G - No
patients
consented
HContracting
delays
I - Rare
diseases
Y
JOther
Comments
Reasons for
delay
correspond
to:
Key service
contact
providing
information
on target
population
absent on
sick leave
will lead to
recruitment
delays.
N/A
N/A
Y
First Patient
now in
Study
Y
Both
NHS
Provider
Extensive
Screening
undertaken
but 95%
patient not
eligible for
inlcusion.
Neither